ACC017

· Jiangsu Aidea Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACC017, covering 2024-12-05 to 2024-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase Ib/IIa Clinical Study of ACC017 Tablets [Phase 1, Phase 2]